Application of Homeopathic Medicines in 50th Millesimal Potency for Treating Skin Conditions- Insights from Clinical Cases
Abstract
LM Potencies, also known as 50 Millesimal Scale Potencies, offer a unique approach to homeopathic treatment, for their reduced aggravation compared to other potency types like Centesimal (CM) potencies mainly in skin affections. A retrospective analysis of 4 clinical cases involving patients with varying skin affections, including multiple warts, psoriasis, and dermatitis, nipple eczema treated with fiftieth millesimal homeopathic potency was conducted. The cases were evaluated based on symptom presentation, remedy selection, and treatment outcomes. For multiple warts, Fluoric Acid 0/1 (16 doses) was prescribed and continued till 0/4 potency; for eczema, Calcarea Carb 0/1 (16 doses) was prescribed and continued till 0/4 potency; for guttate psoriasis, Sulphur 0/1 (16 doses) was prescribed and continued till 0/4 potency; and for nipple eczema, Graphites 0/1 (16 doses) was prescribed and continued till 0/5 potency. Improvement was evident from the first follow-up in all cases, with an average of 3 months required for significant relief of symptoms. The causal relationship between the intervention and outcome is assessed through MONARCH criteria. The observed outcomes indicate notable improvements in several patient’s skin conditions following homeopathic medicines in LM potencies. In MONARCH Criteria assessment, out of 4 cases, 3 cases achieved 08/13 and 1 case achieved 09/13 score. These scores indicate a definite causal attribution of individualized homeopathy in treating skin diseases. This series of clinical cases suggests a potential benefit of using homeopathic medicines in the fiftieth millesimal potency for various skin conditions. While these findings are promising, further prospective studies with larger sample sizes and controlled methodologies are warranted to substantiate these observations and elucidate the mechanisms involved.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.